Research Article
Clinical Outcomes from Unselected “Real-World” Patients with Long Coronary Lesion Receiving 40 mm Biodegradable Polymer Coated Sirolimus-Eluting Stent
Table 1
Baseline demographic characteristics.
| | Characteristics | Indolimus SES
patients |
| | Age (mean ± SD, yrs) | 53.2 ± 11.0 | | Male, (%) | 192 (74.4%) | | Cardiovascular risk | | | Diabetes mellitus, (%) | 83 (32.2%) | | Hypertension, (%) | 99 (38.4%) | | Hypercholesterolemia, (%) | 21 (8.1%) | | Smoker, (%) | 66 (25.6%) | | Family history of CAD, (%) | 10 (3.9%) | | Previous stroke, (%) | 4 (1.6%) | | Previous MI, (%) | 25 (9.7%) | | Previous PCI, (%) | 40 (15.5%) | | Previous CABG, (%) | 7 (2.7%) | | Clinical presentation | | | Stable angina | 18 (7.0%) | | Unstable angina | 66 (25.6%) |
|
|
SES: sirolimus-eluting stent, CAD: coronary artery disease, MI: myocardial infarction, PCI: percutaneous coronary intervention, and CABG: coronary artery bypass grafting.
|
